Occupation of αvβ3-integrin by endogenous ligands modulates IGF-I receptor activation and proliferation of human intestinal smooth muscle
- 1 June 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 290 (6) , G1194-G1202
- https://doi.org/10.1152/ajpgi.00345.2005
Abstract
We have previously shown that endogenous IGF-I regulates growth of human intestinal smooth muscle cells by stimulating proliferation and inhibiting apoptosis. In active Crohn's disease, expression of IGF-I and the αvβ3-integrin receptor ligands fibronectin and vitronectin is increased. The aim of the present study was to determine whether occupation of the αvβ3-receptor influences IGF-I receptor tyrosine kinase activation and function in human intestinal smooth muscle cells. In untreated cells, IGF-I elicited time-dependent tyrosine phosphorylation of its cognate receptor that was maximal within 2 min and sustained for 30 min. In the presence of the αvβ3-ligand fibronectin, IGF-I-stimulated IGF-I receptor activation was augmented. Conversely, in the presence of the αvβ3-specific disintegrin echistatin, IGF-I-stimulated IGF-I receptor tyrosine kinase phosphorylation was inhibited. IGF-I-stimulated IGF-I receptor activation was accompanied by recruitment of the adapter protein IRS-1, activation of Erk1/2, p70S6 kinase, and proliferation. These effects were augmented by fibronectin and attenuated by echistatin. IGF-I also elicited time-dependent recruitment of protein tyrosine phosphatase SHP-2 that coincided with dephosphorylation of the tyrosine phosphorylated IGF-I receptor tyrosine kinase. The αvβ3-disintegrin echistatin accelerated the rate of SHP-2 recruitment and deactivation of the IGF-I receptor tyrosine kinase. The results show that occupancy of the αvβ3-integrin receptor modulates IGF-I-induced IGF-I receptor activation and function in human intestinal muscle cells. We hypothesize that the concomitant increases in the expression of αvβ3-ligands and of IGF-I in active Crohn's disease may contribute to muscle hyperplasia and stricture formation by acting in concert to augment IGF-I-stimulated IGF-I receptor tyrosine kinase activity and IGF-I-mediated muscle cell growth.Keywords
This publication has 40 references indexed in Scilit:
- Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3β activityAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Erratum: Integrins in regulation of tissue development and function. J Pathol; 200: 471–480The Journal of Pathology, 2003
- Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor SignalingMolecular and Cellular Biology, 2003
- SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF β-receptorOncogene, 2002
- Regulation of Insulin-like Growth Factor I Receptor Dephosphorylation by SHPS-1 and the Tyrosine Phosphatase SHP-2Journal of Biological Chemistry, 2002
- Tyr612 and Tyr632 in Human Insulin Receptor Substrate-1 Are Important for Full Activation of Insulin-Stimulated Phosphatidylinositol 3-Kinase Activity and Translocation of GLUT4 in Adipose CellsEndocrinology, 2001
- Coupling of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase to Gi2 in Human Intestinal Smooth MuscleJournal of Biological Chemistry, 2001
- Substrate Specificity of αvβ3Integrin-mediated Cell Migration and Phosphatidylinositol 3-Kinase/AKT Pathway ActivationJournal of Biological Chemistry, 2000
- Synthetic V 3 Antagonists Inhibit Insulin-Like Growth Factor-I-Stimulated Smooth Muscle Cell Migration and ReplicationEndocrinology, 1999
- The expression of integrins and cadherins in normal human uterus and uterine leiomyomasAmerican Journal of Obstetrics and Gynecology, 1996